CDSCO Eases Rules for Biopharma Research, Will Accept Lab Biosafety Committee Approvals
New Delhi: With the aim of streamlining the regulatory process for biopharmaceutical manufacturers engaged in vaccine, recombinant DNA, and other biological product development, the Central Drugs Standard Control Organization (CDSCO) has issued a circular announcing that approvals granted by Institutional Biosafety Committees (IBSC) will now be accepted for seeking permission to manufacture test items for […]